Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Unlike conventional sleep aids that often come with a host of side effects, DSIP offers a more natural approach to achieving restorative sleep
Solution: Always use a validated peptide calculator and double-check calculations
The right choice often comes down to your goals: rapid release suits those seeking faster absorption and upper digestive system support, while delayed release is well-suited for more ongoing support for gut health and general wellness
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Epithalon sits at the intersection of gerontological research and clinical longevity practice
You get clean energy, sustained focus, and zero crashexactly what you need to perform when it matters
